This inventor holds 5 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Duke University. Active years: 2019-2025.
Company Filing History:
Years Active: 2019-2025
Title: The Innovative Contributions of Elizabeth Gottlin
Introduction
Elizabeth Gottlin is a prominent inventor based in Durham, NC (US), known for her significant contributions to the field of biomedical research. With a total of five patents to her name, she has made remarkable strides in the development of therapies targeting complement factor H.
Latest Patents
Among her latest patents are innovative inhibitors of complement factor H. These include anti-CFH antibodies and small molecules, along with methods for utilizing these inhibitors effectively. Her work focuses on methods of inhibiting complement factor H (CFH) by administering an antibody that binds to CFH, showcasing her commitment to advancing medical science.
Career Highlights
Elizabeth Gottlin is affiliated with Duke University, where she continues to push the boundaries of research and innovation. Her work has not only contributed to the academic community but has also paved the way for potential therapeutic applications in various medical conditions.
Collaborations
She has collaborated with esteemed colleagues such as Edward F Patz, Jr. and Michael J Campa, further enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Elizabeth Gottlin's innovative work in the field of complement factor H inhibitors exemplifies her dedication to advancing medical research. Her contributions are significant and continue to inspire future innovations in the biomedical field.